Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Doug Coyle

Showing results (11-20 of 186) with videos related to

Pageof 19
Sort By:
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|August 31, 2006
Dealing with alcoholismTiina Podymow, Jeff Turnbull, Doug Coyle
International Journal of Technology Assessment in Health Care|June 21, 2007
Value of information analysis for a new technology: computer-assisted total knee replacementHengjin Dong, Doug Coyle, Martin Buxton
The Journal of Rheumatology|March 5, 2013
Biologic drug access and juvenile idiopathic arthritis in Canada: improving collaboration between clinician experts and fundersEyal Cohen, Allan Grill, Doug Coyle
The Science of the Total Environment|May 16, 2020
An assessment of uncertainty using two different modelling techniques to estimate the cost effectiveness of mitigating radon in existing housing in CanadaJanet Gaskin, Jeff Whyte, Doug Coyle
Plos One|December 18, 2014
What guidance are researchers given on how to present network meta-analyses to end-users such as policymakers and clinicians? A systematic reviewShannon M Sullivan, Doug Coyle, George Wells
Clinicoeconomics and Outcomes Research : CEOR|April 23, 2016
Designing economic evaluations to facilitate optimal decisions: the need to avoid biasKaren M Lee, Kathryn Coyle, Doug Coyle
Pharmacoeconomics|March 6, 2021
The Continued Need for Transparent Evidence on the Cost Effectiveness of Drugs for Rare DiseasesJesse Elliott, George A Wells, Doug Coyle
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 28, 2015
What Guidance are Economists Given on How to Present Economic Evaluations for Policymakers? A Systematic ReviewShannon M Sullivan, George Wells, Doug Coyle
CMAJ Open|January 17, 2023
Universal ophthalmia neonatorum prophylaxis in Ontario: a cost-effectiveness analysisEllen C Rowlands Snyder, Elspeth McGregor, Doug Coyle
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|December 23, 2009
Cost-effectiveness of self-monitoring of blood glucose in patients with type 2 diabetes mellitus managed without insulinChris Cameron, Doug Coyle, Ehud Ur, et al.
Pageof 19

Showing results (11-20 of 186) with videos related to

Sort By:
Pageof 19
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|August 31, 2006
Dealing with alcoholismTiina Podymow, Jeff Turnbull, Doug Coyle
International Journal of Technology Assessment in Health Care|June 21, 2007
Value of information analysis for a new technology: computer-assisted total knee replacementHengjin Dong, Doug Coyle, Martin Buxton
The Journal of Rheumatology|March 5, 2013
Biologic drug access and juvenile idiopathic arthritis in Canada: improving collaboration between clinician experts and fundersEyal Cohen, Allan Grill, Doug Coyle
The Science of the Total Environment|May 16, 2020
An assessment of uncertainty using two different modelling techniques to estimate the cost effectiveness of mitigating radon in existing housing in CanadaJanet Gaskin, Jeff Whyte, Doug Coyle
Plos One|December 18, 2014
What guidance are researchers given on how to present network meta-analyses to end-users such as policymakers and clinicians? A systematic reviewShannon M Sullivan, Doug Coyle, George Wells
Clinicoeconomics and Outcomes Research : CEOR|April 23, 2016
Designing economic evaluations to facilitate optimal decisions: the need to avoid biasKaren M Lee, Kathryn Coyle, Doug Coyle
Pharmacoeconomics|March 6, 2021
The Continued Need for Transparent Evidence on the Cost Effectiveness of Drugs for Rare DiseasesJesse Elliott, George A Wells, Doug Coyle
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 28, 2015
What Guidance are Economists Given on How to Present Economic Evaluations for Policymakers? A Systematic ReviewShannon M Sullivan, George Wells, Doug Coyle
CMAJ Open|January 17, 2023
Universal ophthalmia neonatorum prophylaxis in Ontario: a cost-effectiveness analysisEllen C Rowlands Snyder, Elspeth McGregor, Doug Coyle
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|December 23, 2009
Cost-effectiveness of self-monitoring of blood glucose in patients with type 2 diabetes mellitus managed without insulinChris Cameron, Doug Coyle, Ehud Ur, et al.
Pageof 19